Stocks & Investing
Fri, September 27, 2024
[ Fri, Sep 27th 2024
] - WOPRAI
Fri, September 6, 2024
[ Fri, Sep 06th 2024
] - WOPRAI
Thu, August 1, 2024
[ Thu, Aug 01st 2024
] - WOPRAI
Fri, December 15, 2023
[ Fri, Dec 15th 2023
] - WOPRAI
Fri, September 22, 2023
[ Fri, Sep 22nd 2023
] - WOPRAI
Tue, May 2, 2023
[ Tue, May 02nd 2023
] - WOPRAI
Mon, May 1, 2023
[ Mon, May 01st 2023
] - WOPRAI
Thu, September 29, 2022
[ Thu, Sep 29th 2022
] - WOPRAI
Wed, March 16, 2022
[ Wed, Mar 16th 2022
] - WOPRAI
Fri, December 3, 2021
[ Fri, Dec 03rd 2021
] - WOPRAI
[ Fri, Dec 03rd 2021
] - WOPRAI
Fri, September 10, 2021
[ Fri, Sep 10th 2021
] - WOPRAI
Greg Harrison Maintained (TVTX) at Strong Buy with Decreased Target to $18 on, Sep 27th, 2024
Greg Harrison of B of A Securities, Maintained "Travere Therapeutics, Inc." (TVTX) at Strong Buy with Decreased Target from $19 to $18 on, Sep 27th, 2024.
Greg has made no other calls on TVTX in the last 4 months.
There are 5 other peers that have a rating on TVTX. Out of the 5 peers that are also analyzing TVTX, 1 agrees with Greg's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Allison Bratzel of "Piper Sandler" Maintained at Hold with Increased Target to $12 on, Friday, August 2nd, 2024
These are the ratings of the 4 analyists that currently disagree with Greg
- Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $23 on, Friday, September 13th, 2024
- Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $23 on, Tuesday, September 10th, 2024
- Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $16 on, Friday, August 2nd, 2024
- Carter Gould of "Barclays" Maintained at Buy with Increased Target to $14 on, Friday, August 2nd, 2024
